Kintor has started Phase 3 trial in China for Pyrilutamide

pegasus2

Senior Member
My Regimen
Reaction score
4,504
A year of sales wouldn’t cover development costs… not even close.
I've seen drugs get approved that will never recoup their development costs lol
 

Ljames

Member
My Regimen
Reaction score
26
Bad news guys. Kintor has delayed the publication of phase II results again to September 2022.
Unfortunately, really looks like an other scam.
I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
 

Hard_science_only

New Member
My Regimen
Reaction score
1
I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
Probably to keep the stock price elevated till they can raise new funds, management can cash out, other product candidates can progress to more promising stages etc.
 

klbt

New Member
My Regimen
Reaction score
5

Attachments

  • 90d3546a-4986-4edb-bf09-d84df6457465.png
    90d3546a-4986-4edb-bf09-d84df6457465.png
    245.3 KB · Views: 242
Top